[go: up one dir, main page]

NO973876D0 - Human-DNase I-varianter - Google Patents

Human-DNase I-varianter

Info

Publication number
NO973876D0
NO973876D0 NO973876A NO973876A NO973876D0 NO 973876 D0 NO973876 D0 NO 973876D0 NO 973876 A NO973876 A NO 973876A NO 973876 A NO973876 A NO 973876A NO 973876 D0 NO973876 D0 NO 973876D0
Authority
NO
Norway
Prior art keywords
variants
human dnase
actin
relates
resistant
Prior art date
Application number
NO973876A
Other languages
English (en)
Other versions
NO326612B1 (no
NO973876L (no
Inventor
Robert A Lazarus
Steven Shak
Jana S Ulmer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22248728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO973876(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to NO19973876A priority Critical patent/NO326612B1/no
Publication of NO973876D0 publication Critical patent/NO973876D0/no
Publication of NO973876L publication Critical patent/NO973876L/no
Publication of NO326612B1 publication Critical patent/NO326612B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19973876A 1995-02-24 1997-08-22 Variant av human DNase I, isolert nukleinsyre og preparat for reduksjon av viskoelastisiteten til pulmonale sekreter. NO326612B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19973876A NO326612B1 (no) 1995-02-24 1997-08-22 Variant av human DNase I, isolert nukleinsyre og preparat for reduksjon av viskoelastisiteten til pulmonale sekreter.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/002366 WO1996026278A1 (en) 1995-02-24 1995-02-24 HUMAN DNase I VARIANTS
NO19973876A NO326612B1 (no) 1995-02-24 1997-08-22 Variant av human DNase I, isolert nukleinsyre og preparat for reduksjon av viskoelastisiteten til pulmonale sekreter.

Publications (3)

Publication Number Publication Date
NO973876D0 true NO973876D0 (no) 1997-08-22
NO973876L NO973876L (no) 1997-10-24
NO326612B1 NO326612B1 (no) 2009-01-19

Family

ID=22248728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973876A NO326612B1 (no) 1995-02-24 1997-08-22 Variant av human DNase I, isolert nukleinsyre og preparat for reduksjon av viskoelastisiteten til pulmonale sekreter.

Country Status (22)

Country Link
EP (1) EP0811068B1 (no)
JP (1) JPH11505408A (no)
AT (1) ATE230027T1 (no)
AU (1) AU720635B2 (no)
BG (1) BG64061B1 (no)
BR (1) BR9510323A (no)
CA (1) CA2210871C (no)
CZ (1) CZ288633B6 (no)
DE (1) DE69529235T2 (no)
DK (1) DK0811068T3 (no)
ES (1) ES2188653T3 (no)
HU (1) HU223272B1 (no)
MX (1) MX9706428A (no)
NO (1) NO326612B1 (no)
PL (1) PL180773B1 (no)
PT (1) PT811068E (no)
RU (1) RU2215787C2 (no)
SI (1) SI9520153B (no)
SK (1) SK283850B6 (no)
UA (2) UA66749C2 (no)
WO (1) WO1996026278A1 (no)
ZA (1) ZA961419B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284191B6 (sk) * 1995-02-24 2004-10-05 Genentech, Inc. Aktín-rezistentný variant humánnej DNázy I
US6391607B1 (en) 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
DE60335602D1 (de) 2002-12-18 2011-02-17 Roche Diagnostics Gmbh Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
EP1433842B1 (en) 2002-12-18 2011-01-05 Roche Diagnostics GmbH Recombinant bovine pancreatic desoxyribonuclease I with high specific activity
WO2013114373A1 (en) * 2012-02-01 2013-08-08 Protalix Ltd. Inhalable liquid formulations of dnase i

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE358176T1 (de) * 1988-12-23 2007-04-15 Genentech Inc Menschliche dnase
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I

Also Published As

Publication number Publication date
WO1996026278A1 (en) 1996-08-29
AU1970395A (en) 1996-09-11
DK0811068T3 (da) 2003-03-10
SI9520153B (sl) 2004-10-31
PT811068E (pt) 2003-04-30
HU223272B1 (hu) 2004-04-28
ATE230027T1 (de) 2003-01-15
BG64061B1 (bg) 2003-11-28
BG101846A (en) 1998-07-31
SK114797A3 (en) 1998-02-04
UA65523C2 (en) 2004-04-15
RU2215787C2 (ru) 2003-11-10
PL180773B1 (pl) 2001-04-30
EP0811068A1 (en) 1997-12-10
CZ267797A3 (cs) 1998-01-14
AU720635B2 (en) 2000-06-08
JPH11505408A (ja) 1999-05-21
NO326612B1 (no) 2009-01-19
UA66749C2 (en) 2004-06-15
MX9706428A (es) 1997-11-29
CA2210871C (en) 2009-04-07
BR9510323A (pt) 1997-11-11
CZ288633B6 (cs) 2001-08-15
SI9520153A (sl) 1998-06-30
SK283850B6 (sk) 2004-03-02
HUT77422A (hu) 1998-04-28
NO973876L (no) 1997-10-24
ES2188653T3 (es) 2003-07-01
DE69529235T2 (de) 2003-09-04
DE69529235D1 (de) 2003-01-30
CA2210871A1 (en) 1996-08-29
ZA961419B (en) 1997-08-22
PL321890A1 (en) 1997-12-22
EP0811068B1 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
DK0910647T3 (da) Human DNase i hyperaktive varianter
WO1996034953A3 (en) Cd16-ii variants
ATE330967T1 (de) An her2 bindende peptidverbindungen
PT1082131E (pt) Imuno-regulador
ATE326981T1 (de) Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
FI972170A0 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
WO1998011234A3 (en) Human protein kinases
DE69529235D1 (de) Menschliche dnase i varianten
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
ATE278011T1 (de) Human dnase ii
MX9706429A (es) Variantes de dnasa i humana.
CA2242562A1 (en) Human dnase resistant to actin inhibition
WO2002050116A3 (en) Adhesion molecule protein

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees